New York, NY, October 10, 2012 --(PR.com
)-- Emilior Pharmaceutical Compounding, Inc., a state-of-the-art compounding pharmacy, today announced that Dr Emil J. Haldey, the Company’s President, has been invited to speak at Dermatology Grand Rounds at Mount Sinai Medical Center in New York City. Dr Emil J. Haldey will discuss history, rationale, and benefits of pharmacy compounding for the modern dermatology practice. His talk will cover common dermatologic pathologies including acne, psoriasis, melasma, dermatitis, etc and custom therapy considerations for these conditions.
Conference: Dermatology Grand Rounds
Location: Mount Sinai Medical Center in New York City
Speaker: Dr Emil J. Haldey, President, Emilior Pharmaceutical Compounding, Inc.
Topic: Compounding Options in Medicine: Special Focus on Dermatology
Date: October 18, 2012
About Emilior Pharmaceutical Compounding, Inc.: Emilior Pharmaceutical Compounding, Inc. (Emilior) is a state-of-the-art compounding pharmacy.
Emilior ’s specializations cover a wide spectrum ideal for everyone’s pharmaceutical needs including: pain management, anti-aging & functional medicine, holistic health care, hospice needs, dermatology and health & wellness.
Emilior’s compounding laboratory is staffed with professional compounding pharmacists and technicians. It utilizes modern state-of-the-art equipment and technology, innovative medication dosing devices and high-quality ingredients. It consistently obtains only the best quality ingredients from trusted FDA registered facilities.
For more information visit www.emilior.com or call us at 1-855-I-COMPOUND (426-6768).